268EGP
- Active ingredient
- dapagliflozin
- Strength
- 5 mg
- Form
- tablet
- Manufacturer
- liptis
- Route
- oral.solid
Uses
Used to improve glycemic control in type 2 diabetes and reduce heart failure-related hospitalization risk.
Do not use if
Contraindicated in patients with serious hypersensitivity to dapagliflozin.
Side effects
Genital infections, urinary tract infections, dehydration, dizziness, and increased urination may occur.
Warnings
May cause ketoacidosis, volume depletion, and serious urinary tract infections.
How it works
SGLT2 inhibitor that increases urinary glucose excretion by reducing renal glucose reabsorption.
Storage
Store at room temperature according to product labeling.